Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 509

1.

Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.

Mulloy DP, Bhamidipati CM, Stone ML, Ailawadi G, Kron IL, Kern JA.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):566-73; discussion 573-4. doi: 10.1016/j.jtcvs.2012.10.034. Epub 2012 Dec 13.

2.

Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037. Epub 2010 May 5.

3.

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.

Kamdar F, John R, Eckman P, Colvin-Adams M, Shumway SJ, Liao K.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):575-81. doi: 10.1016/j.jtcvs.2012.09.095.

4.

Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.

Arnaoutakis GJ, George TJ, Kilic A, Weiss ES, Russell SD, Conte JV, Shah AS.

J Thorac Cardiovasc Surg. 2011 Nov;142(5):1236-45, 1245.e1. doi: 10.1016/j.jtcvs.2011.07.019. Epub 2011 Aug 11.

5.

National Trends in Utilization, Mortality, Complications, and Cost of Care After Left Ventricular Assist Device Implantation From 2005 to 2011.

Shah N, Agarwal V, Patel N, Deshmukh A, Chothani A, Garg J, Badheka A, Martinez M, Islam N, Freudenberger R.

Ann Thorac Surg. 2016 Apr;101(4):1477-84. doi: 10.1016/j.athoracsur.2015.09.013. Epub 2015 Nov 14.

PMID:
26588867
6.

Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-to-transplant program for patients with heart failure.

Pulikottil-Jacob R, Suri G, Connock M, Kandala NB, Sutcliffe P, Maheswaran H, Banner NR, Clarke A.

J Heart Lung Transplant. 2014 Apr;33(4):350-8. doi: 10.1016/j.healun.2014.01.003. Epub 2014 Jan 19.

7.

Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.

Tsukashita M, Takayama H, Takeda K, Han J, Colombo PC, Yuzefpolskaya M, Topkara VK, Garan AR, Mancini DM, Kurlansky PA, Naka Y.

J Thorac Cardiovasc Surg. 2015 Nov;150(5):1352-60, 1361.e1-2. doi: 10.1016/j.jtcvs.2015.07.012. Epub 2015 Jul 14.

8.

The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.

Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J.

Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. Review.

9.

Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation.

Moreno SG, Novielli N, Cooper NJ.

J Heart Lung Transplant. 2012 May;31(5):450-8. doi: 10.1016/j.healun.2011.10.017. Epub 2011 Nov 23.

PMID:
22115674
10.

Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.

Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, Massey T, Milano CA, Moazami N, Sundareswaran KS, Farrar DJ; HeartMate II Clinical Investigators.

J Thorac Cardiovasc Surg. 2010 May;139(5):1316-24. doi: 10.1016/j.jtcvs.2009.11.020. Epub 2010 Feb 4.

11.

Institutional Cost Comparison Between Heart Transplants and Left Ventricular Assist Device Implantations.

Chimanji N, Kilic A, Hasan A, Higgins RS, Whitson BA, Kilic A.

Exp Clin Transplant. 2016 Dec;14(6):656-659. doi: 10.6002/ect.2015.0213. Epub 2016 Apr 7.

12.

Cost of 1-year left ventricular assist device destination therapy in chronic heart failure: a comparison with heart transplantation.

Droogne W, Jacobs S, Van den Bossche K, Verhoeven J, Bostic RR, Vanhaecke J, Van Cleemput J, Rega F, Meyns B.

Acta Clin Belg. 2014 Jun;69(3):165-70. doi: 10.1179/2295333714Y.0000000017. Epub 2014 Mar 20.

PMID:
24820923
13.

Use of left ventricular assist device (HeartMate II): a Singapore experience.

Lim CP, Sivathasan C, Tan TE, Lim CH, Kerk KL, Sim DK.

Artif Organs. 2014 Jul;38(7):543-8. doi: 10.1111/aor.12247. Epub 2014 Jan 7.

PMID:
24392937
14.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
15.

Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support.

Takeda K, Takayama H, Kalesan B, Uriel N, Colombo PC, Jorde UP, Yuzefpolskaya M, Mancini DM, Naka Y.

J Heart Lung Transplant. 2015 Jan;34(1):89-99. doi: 10.1016/j.healun.2014.09.007. Epub 2014 Sep 8.

PMID:
25444372
16.

Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients.

Alba AC, Alba LF, Delgado DH, Rao V, Ross HJ, Goeree R.

Circulation. 2013 Jun 18;127(24):2424-35. doi: 10.1161/CIRCULATIONAHA.112.000194. Epub 2013 May 22.

17.

Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure.

Long EF, Swain GW, Mangi AA.

Circ Heart Fail. 2014 May;7(3):470-8. doi: 10.1161/CIRCHEARTFAILURE.113.000807. Epub 2014 Feb 21.

18.

Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices.

John R, Liao K, Kamdar F, Eckman P, Boyle A, Colvin-Adams M.

J Thorac Cardiovasc Surg. 2010 Aug;140(2):447-52. doi: 10.1016/j.jtcvs.2010.03.006.

19.

Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries.

Hernandez AF, Shea AM, Milano CA, Rogers JG, Hammill BG, O'Connor CM, Schulman KA, Peterson ED, Curtis LH.

JAMA. 2008 Nov 26;300(20):2398-406. doi: 10.1001/jama.2008.716.

20.

Heart transplant and left ventricular assist device costs.

Digiorgi PL, Reel MS, Thornton B, Burton E, Naka Y, Oz MC.

J Heart Lung Transplant. 2005 Feb;24(2):200-4.

PMID:
15701438

Supplemental Content

Support Center